Literature DB >> 31604104

Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.

Samantha R Goldburg1, Bruce E Strober2, Michael J Payette3.   

Abstract

Hidradenitis suppurativa (HS) is an inflammatory disorder that is characterized by chronic deep-seated nodules, abscesses, fistulae, sinus tracts, and scars in the axilla, inguinal area, submammary folds, and perianal area. This disfiguring condition is accompanied by pain, embarrassment, and a significantly decreased quality of life. Although the mechanism of HS has not been entirely elucidated, lesion formation is believed to center around follicular hyperkeratosis within the pilosebaceous-apocrine unit. Recent research has provided new insight into the role of cytokines in the pathogenesis of HS, helping close some existing knowledge gaps in the development of this condition. The first article in this continuing medical education series reviews HS epidemiology, clinical presentation, and classification. We also provide an update on the most recent understanding of HS pathogenesis, including the central role of inflammatory cytokines and other contributing factors, such as genetics, hormones, and pathogenic microorganisms.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-17; TNF-α; hidradenitis; hidradenitis suppurativa; pathogenesis

Mesh:

Substances:

Year:  2019        PMID: 31604104     DOI: 10.1016/j.jaad.2019.08.090

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  30 in total

1.  Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24.

Authors:  Servando E Marron; Manuel Gomez-Barrera; Lucía Tomas Aragones; Ana Goni-Navarro; Eva Vilarrasa-Rull; Rosa María Diaz-Diaz; Francisco Javier Garcia-Latasa de Aranibar; Ricardo Campos-Rodenas; Victoria Fuentelsaz Del Barrio; Yolanda Gilaberte-Calzada; Tamara Gracia-Cazaña; Anna María Morales-Callaghan; Sandra Ros-Abarca; María Blanca Madrid-Alvarez; Lluís Puig
Journal:  Acta Derm Venereol       Date:  2021-08-25       Impact factor: 3.875

Review 2.  The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.

Authors:  Marisa E Luck; Joy Tao; Eden P Lake
Journal:  Am J Clin Dermatol       Date:  2022-09-18       Impact factor: 6.233

3.  Hidradenitis Suppurativa Leads to Increased Risk of Wound-Related Complications following Total Joint Arthroplasty.

Authors:  Michael J Gouzoulis; Alexander J Kammien; Dennis L Caruana; Daniel H Wiznia; Jonathan N Grauer
Journal:  Arthroplast Today       Date:  2022-06-24

4.  Hidradenitis Suppurativa International Online Community: Patient Characteristics and a Novel Model of Treatment Effectiveness.

Authors:  Jen Barak-Levitt; Ron Held; Yossi Synett; Noa Kremer; Emmilia Hodak; Shany Sherman
Journal:  Acta Derm Venereol       Date:  2022-04-04       Impact factor: 3.875

Review 5.  [Pathogenesis of hidradenitis suppurativa/acne inversa].

Authors:  G Nikolakis; G Kokolakis; K Kaleta; K Wolk; R Hunger; R Sabat; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751

6.  Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Jing-Wun Lu; Yu-Wen Huang; Tai-Li Chen
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

7.  Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.

Authors:  Kristina Navrazhina; John W Frew; Patricia Gilleaudeau; Mary Sullivan-Whalen; Sandra Garcet; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2021-02-03       Impact factor: 14.290

8.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

9.  Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.

Authors:  Ester Del Duca; Paola Morelli; Luigi Bennardo; Cosimo Di Raimondo; Steven Paul Nisticò
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

10.  Intermammary Hidradenitis Suppurativa: Considerations on a Unique Presentation.

Authors:  Ana Luísa João; Nélia Cunha; Joana Cabete
Journal:  Skin Appendage Disord       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.